伊朗全国调查显示94.26%成年人处于CKM综合征1–4期,2期占65.73%
Patterns of cardiovascular-kidney-metabolic (CKM) syndrome stages and prevalence of lifestyle risk factors in a nationally representative iranian population study
基于2021年STEPS调查16,208名25岁以上伊朗成年人的二次分析,94.26%符合CKM综合征1–4期标准,其中2期占比最高(65.73%),1期为13.08%。高血压和代谢综合征是最常见的心血管代谢疾病,3期和4期参与者中分别有63.83%和57.89%报告至少两项不健康生活方式因素,果蔬摄入不足在各期均最常见。作者表示,该横断面分析提供的是全国及地区分期分布的描述性证据。
- Article
- Open access
- Published: 27 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Cardiovascular-kidney-metabolic (CKM) syndrome contributes substantially to mortality and places a substantial burden on healthcare systems. Despite the high prevalence of cardiac, renal, and metabolic disorders in Iran, nationally representative data describing the CKM stage distribution and associated unhealthy lifestyle factors are lacking. We aimed to investigate the national pattern of CKM stages and the prevalence of unhealthy lifestyle behaviors among Iranian adults. This secondary analysis used data from the 2021 STEPS survey. Sociodemographic characteristics, lifestyle factors, and renal, metabolic, and cardiovascular risk indicators were presented across CKM stages (0–4). Geographical variations in stage distribution were also assessed. Categorical variables were presented as weighted percentages with corresponding 95% confidence intervals (CIs). A total of 16,208 participants aged ≥ 25 years were analyzed. Overall, 94.26% of participants met the criteria for CKM stages 1–4, with stage 2 accounting for the largest proportion (65.73%, 95% CI: 64.68, 66.78), followed by stage 1 (13.08%, 95% CI: 12.35, 13.82). Hypertension and metabolic syndrome were the most prevalent cardiometabolic conditions, whereas moderate- to high-risk and very high-risk CKD were the least prevalent. Geographic variations were observed, with northwestern and southwestern provinces showing high stage 3 prevalence but relatively low stage 4 prevalence. Overall, 63.83% (95% CI: 59.74, 67.92) of participants in stage 3 and 57.89% (95% CI: 54.20, 61.58) in stage 4 reported at least two unhealthy lifestyle factors, while 10.19% (95% CI: 7.77, 12.61) and 11.85% (95% CI: 8.98, 14.72), respectively, reported three or more factors. Insufficient fruit and vegetable intake was the most prevalent unhealthy lifestyle factor across all CKM stages. CKM syndrome affects most Iranian adults, predominantly at stage 2. These findings provide descriptive evidence of the national and regional distribution of CKM stages.
Abbreviations
- CKM:
-
Cardiovascular-kidney-metabolic
- AHA:
-
The American Heart Association
- CKD:
-
Chronic kidney disease
- CVD:
-
Cardiovascular diseases
- BMI:
-
Body mass index
- STEPS:
-
STEPwise approach to non-communicable disease
- WHO:
-
The world health organization
- NCD:
-
Non-communicable disease
- STROBE:
-
The strengthening the reporting of observational studies in epidemiology
- PCA:
-
Principal component analysis
- GPAQ-v2:
-
Global physical activity questionnaire
- MET:
-
Metabolic equivalent of task
- WC:
-
Waist circumference
- HDL-C:
-
High-density lipoprotein-cholesterol
- TC:
-
Total cholesterol
- TG:
-
Triglycerides
- FBS:
-
Fasting blood glucose
- HbA1C:
-
Hemoglobin A1c
- LDL-C:
-
Low-density lipoprotein-cholesterol
- eGFR:
-
Estimated glomerular filtration rate
- PREVENT:
-
Predicting risk of cardiovascular disease EVENTs
- DM:
-
Diabetes mellitus
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- KDIGO:
-
The kidney disease improving global outcomes
- CIs:
-
Confidence intervals
- UI:
-
Uncertainty interval
- DALYs:
-
Disability-adjusted life years
- WHO-PEN:
-
The WHO package of essential non-communicable diseases
- JACC:
-
The journal of the American college of cardiology
- DASH:
-
The dietary approaches to stop hypertension
- ASCVD:
-
Atherosclerotic cardiovascular disease
Acknowledgements
This research was supported by the National Institute of Health Research of the Islamic Republic of Iran and the Tehran University of Medical Sciences. We would like to express our sincere appreciation to all colleagues at the Non‑Communicable Diseases Research Center (NCDRC), Diabetes Research Center, and the Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences for their invaluable support and collaboration throughout this study.
Funding
This work was undertaken as part of the larger project titled “Personalized Medicine Applications in Clinical Practice in Iran: A New Strategy for Improving Public Health”. It was supported by grants awarded to Dr Mohammad Reza Amini from the following research centres at the Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran: the Non-Communicable Diseases Research Center, the Personalized Medicine Research Center, and the Diabetes Research Center. Additional support was provided by the Vice-Presidency for Science, Technology and Knowledge-Based Economy Affairs, Islamic Republic of Iran [Grant No. 90680].
Author information
Author notes
Hosein Ataei-Goujani and Mina Mirzad contributed equally to this work: Hosein Ataei-Goujani and Mina Mirzad. Yosra Azizpour and Mandana Hasanzad contributed equally as corresponding authors.
Authors and Affiliations
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Hosein Ataei-Goujani, Mina Mirzad & Yosra Azizpour
Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
Hosein Ataei-Goujani
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Mina Mirzad & Bagher Larijani
Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Reza Amini
Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Mandana Hasanzad
Medical Genomic Research Center, TeMS.C., Islamic Azad University, Tehran, Iran
Mandana Hasanzad
Authors
- Hosein Ataei-Goujani
- Mina Mirzad
- Mohammad Reza Amini
- Yosra Azizpour
- Mandana Hasanzad
- Bagher Larijani
Corresponding authors
Correspondence to Yosra Azizpour or Mandana Hasanzad.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical considerations
The current study involved human participants that were reviewed and approved by the Ethical Committee of the National Institute of Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran (ID: IR.TUMS.EMRI.REC.1404.034). Moreover, the study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Furthermore, the patients/participants granted their written informed consent to engage in this study. The study results were reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Ataei-Goujani, H., Mirzad, M., Amini, M.R. et al. Patterns of cardiovascular-kidney-metabolic (CKM) syndrome stages and prevalence of lifestyle risk factors in a nationally representative iranian population study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76826-w
Received: 06 April 2026
Accepted: 15 October 2026
Published: 27 October 2026
DOI: https://doi.org/10.1038/s41598-026-76826-w
Keywords
来源:Nature 健康护理主题 · nature.com